Predictors of Outcome After Sirolimus-Eluting Stent Implantation for Complex In-Stent Restenosis

Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents

“…In contrast, Kuchulakanti et al 26 found no difference in target lesion revascularization rates between 403 patients with diabetes mellitus and 750 patients without diabetes mellitus. Similarly, in the studies of Berenguer et al 27 and Migliorini et al, 28 diabetes mellitus was not an independent predictor of angiographic and clinical restenosis. Comparable rates of angiographic restenosis rates also were found among patients with (6.4%) and without (8.4%) diabetes mellitus in the diabetes substudy of TAXUS IV trial.…”

Rotational atherectomy for fibro‐calcific coronary artery disease in drug eluting stent era: Procedural outcomes and angiographic follow‐up results

“…Previous studies have shown several predictors of instent restenosis following stent implantation [10,11], including coronary calcification. The similar data from the calcified coronary lesions is lacking.…”

“…Coronary artery stenting with drug eluting stents has shown to be effective in reducing restenosis and target vessel revascularization rates in several randomized trials in wide variety of clinical situations [1][2][3][4][5][6][7][8][9].The risk of restenosis remains high after coronary stenting in complex lesions such as long lesions, fibrocalcific lesions, bifurcations, ostial, and vein graft lesions [10,11]. Adequate lesion preparation before coronary stenting remains crucial in patients with complex lesions to improve outcomes.…”

Long-Term Effectiveness and Safety of Sirolimus Stent Implantation for Coronary In-Stent Restenosis

“…As a real-world registry, the study is inherently limited by a lack of valid control groups using historical controls. However, one should also recognize that many of the DES randomized trials performed for device approval have restricted enrollment criteria, making extrapolation of their findings to the greater population questionable (13). The absence of a systematic late (Ͼ12 months) control coronary angiography did not allow a real estimation of the late catch-up phenomenon with DES in ISR lesions, which, however, seems to be clinically irrelevant.…”